A clinical trial to study the beneficial effects of zinc sulfate in reducing the adverse effects of acute inflammation and calprotectin activity in neonatal sepsis.
Phase 3
- Conditions
- Health Condition 1: null- Neonatal sepsis
- Registration Number
- CTRI/2012/03/002517
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 134
Inclusion Criteria
1. Age <28 days
2. Clinically diagnosed sepsis with two positive sepsis screening tests (mESR, CRP)
3. No antibiotic treatment before enrollment in the study
Exclusion Criteria
1. Major surgical procedures
2. Maternal history of antibiotic therapy before delivery
3. Apgar score <6 at 5 minutes
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method